Tang Siu W, Tang Wayne H, Leonard Brian E
aDepartment of Psychiatry, School of Medicine, University of California, Irvine, California, USA bDepartment of Pharmacology, National University of Ireland, Galway, Ireland cInstitute of Brain Medicine, Hong Kong, China.
Int Clin Psychopharmacol. 2017 Jul;32(4):175-183. doi: 10.1097/YIC.0000000000000172.
Polypharmacy is common in psychiatry. Usage of cognitive enhancers is increasing in the psychiatric population. Many clinicians are not familiar with these new psychoactive compounds. This paper reviews the potential drug-drug interactions when these cognitive enhancers are used together with psychotropic drugs and their confounding effects on diagnosis and clinical management.
多种药物联合使用在精神病学领域很常见。认知增强剂在精神病患者中的使用正在增加。许多临床医生对这些新型精神活性化合物并不熟悉。本文综述了这些认知增强剂与精神药物联合使用时潜在的药物相互作用,以及它们对诊断和临床管理的混杂影响。